Branch retinal vein occlusion as a manifestation of systemic vasculopathy in CADASIL: a multimodal imaging case

Figen Bezci Aygun1, Ceren Özkorkmaz1, Sibel Kadayıfcılar1

  • 1Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.

Ophthalmic Genetics
|October 19, 2025
PubMed

Insights

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) can affect retinal veins, as shown in a case of branch retinal vein occlusion (BRVO). This highlights the importance of regular eye exams for early detection of systemic vascular disease in CADASIL patients.

Area of Science:

  • Ophthalmology
  • Neurology
  • Genetics

Background:

  • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary small vessel disease linked to NOTCH3 gene mutations.
  • While primarily affecting cerebral arterioles, CADASIL shows increasing evidence of systemic vascular involvement.
  • Ocular manifestations, specifically retinal venous abnormalities like branch retinal vein occlusion (BRVO), are rare and poorly understood in CADASIL.

Purpose of the Study:

  • To report a rare case of branch retinal vein occlusion (BRVO) in a patient with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).
  • To emphasize the potential for CADASIL-related vasculopathy to affect the retinal venous system.
  • To highlight the significance of ocular imaging in recognizing systemic microvascular disease.

Main Methods:

  • Case report of a 63-year-old male with decreased vision and floaters.
  • Multimodal ocular imaging to assess retinal abnormalities.
  • Genetic testing to confirm NOTCH3 gene variants.

Main Results:

  • The patient presented with macular edema, intraretinal hemorrhages, and superior temporal BRVO.
  • Genetic analysis confirmed a pathogenic NOTCH3 variant (c.317G>A; p.Cys106Tyr).
  • The patient received intravitreal bevacizumab and dexamethasone implants for management.

Conclusions:

  • CADASIL can manifest with retinal venous system involvement, such as BRVO.
  • Ocular examination and imaging are crucial for identifying systemic microvascular disease in CADASIL.
  • BRVO may be an underrecognized sign of CADASIL, necessitating regular ophthalmic screening and collaborative care.
Abstract